"It's very hard to sort out," says Steven Nissen, lead investigator of the trial that linked Avandia to an increased risk of heart attacks.
"We've got to be careful not to jump to conclusions."
"It's really going to shake things up," Nissen added. "Clinicians have been taught that getting to lower blood sugar is better."
Source
"We've got to be careful not to jump to conclusions."
"It's really going to shake things up," Nissen added. "Clinicians have been taught that getting to lower blood sugar is better."
Source
No comments:
Post a Comment